Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy
Launched by MVZ LEOPOLDINA GMBH · Oct 1, 2020
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
A total of 13 breast cancer patients referred to our clinic for curative radiotherapy were recruited for this pilot study. The women were supposed to undertake a "Paleolithic lifestyle" (PL) intervention consisting of a Paleolithic diet and daily outdoor activity of at least 30 min duration while undergoing radiotherapy. Body composition was measured weekly by bioimpedance analysis. Blood parameters were assessed before, during, and at the end of radiotherapy. A control group on an unspecified standard diet (SD) was assigned by propensity score matching.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Body mass index \>18 kg/m\^2
- • Karnofsky performance index \>60
- Exclusion Criteria:
- • Metallic body parts
- • Unable to comprehend the intervention
About Mvz Leopoldina Gmbh
mvz leopoldina gmbh is a leading clinical trial sponsor specializing in the development and management of innovative healthcare solutions. With a strong focus on advancing medical research, the organization is committed to conducting high-quality clinical trials that adhere to rigorous regulatory standards. Leveraging a team of experienced professionals and state-of-the-art facilities, mvz leopoldina gmbh collaborates with various stakeholders, including pharmaceutical companies and research institutions, to facilitate the successful progression of novel therapies. Their dedication to improving patient outcomes through evidence-based research underscores their pivotal role in the clinical trial landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Schweinfurt, Bavaria, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials